April 7 (SeeNews) - Slovenian drug maker Krka [LJE:KRKG] said on Monday it will receive damages and legal costs of some 21 million euro ($29 million) following the decision of a London court in a tort proceeding concerning the sale of the Esomeprazole drug in the UK.